Life Sciences Questions on claim interpretation referred to Enlarged Board of Appeal of the EPOGuidance sought on divergence in case law in new case G1/24Read More 01Jul2024 UPC order applies EPO’s standard for added matter by way of intermediate generalisationIs the EPO’s ‘gold standard’ for added matter going to be applied by the UPC when examining patent validity? A recent order denying a preliminary injunction might suggest soRead More 25Jun2024 Financial Times: Europe’s Leading Patent Law Firms 2024Carpmaels & Ransford awarded gold rankingRead More 13Jun2024 The UPC – one year inA strong start from the new Court in its first 12 months and many more milestones to comeRead More 31May2024 New acceleration mechanism for EPO oppositionsEPO may issue opposition decisions within 8 months where there are co-pending national or UPC proceedingsRead More 14May2024 mRNA vaccines at the EPO and beyondIncreasing patent filings for mRNA technology coincide with high-stakes litigation over COVID-19 vaccines in national courtsRead More 07May2024 Who’s Who Legal: Life Sciences 2024Three Carpmaels partners recognised as leaders in life sciences patent litigationRead More 25Apr2024 Carpmaels in Conversation: Ep.32 – Can trade secrets help innovation in healthcare?Episode overviewRead More 03Apr2024 Creativity from complexity: patentability opportunities for multispecific antibodiesMultispecific antibodies can face many of the same patentability objections as monospecific antibodies, but their greater structural complexity gives applicants more options in argument and amendmentRead More 13Mar2024 Decision making at the UPC: Life sciences, Robotics, and MedTechSector-specific factors to consider when deciding on a strategy for using the UPC systemRead More 07Dec2023<1234567…26> Type Firm News Insights PodcastsServiceProtectDealDisputeUPCSectorHealthcare+Energy+Life SciencesChemistryMaterialsEngineeringTechCreativeArchive2026OctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2025DecemberNovemberOctoberSeptemberAugustJulyJuneAprilMarchFebruaryJanuary2024DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2023DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2022DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2021DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2020DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2019DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2018DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2017DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2016DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2015DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchFebruaryJanuary2014DecemberNovemberOctoberAugustJulyJuneMayAprilMarchFebruaryJanuary2013DecemberNovemberOctoberSeptemberAugustJulyJuneMayAprilMarchJanuary2012NovemberJulyJuneMayAprilFebruaryJanuary
